Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis

European Heart Journal Cardiovascular Imaging

Volumn 20, Issue 4, 2019, Pages 467-474

  Werner, Rudolf A ^a,b,c   Wakabayashi, Hiroshi ^b   Bauer, Jochen ^c   Schütz, Claudia ^b   Zechmeister, Christina ^b   Hayakawa, Nobuyuki ^b   Javadi, Mehrbod S ^a   Lapa, Constantin ^b   Jahns, Roland ^b   Ergün, Süleyman ^c   Jahns, Valerie ^b   Higuchi, Takahiro ^b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

18F FDG; inflammation; myocarditis; personalized treatment; PET

Indexed keywords

CARDIAC MYOSIN; CD34 ANTIGEN; CD68 ANTIGEN; FLUORODEOXYGLUCOSE F 18; FREUND ADJUVANT; HERMES ANTIGEN; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARDIAC MUSCLE; CONTROLLED STUDY; EX VIVO STUDY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; FEMALE; HEART MUSCLE BIOPSY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LONGITUDINAL STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MORTALITY RATE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; ACUTE DISEASE; ANIMAL; AUTOIMMUNE DISEASE; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE MODEL; INFLAMMATION; LEWIS RAT; MYOCARDITIS;

ACUTE DISEASE; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; FLUORODEOXYGLUCOSE F18; INFLAMMATION; MYOCARDITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW;

EID: 85063647307     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jey119     Document Type: Article

References (44)

1. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006;113:876-90.
2. Noren GR, Staley NA, Bandt CM, Kaplan EL. Occurrence of myocarditis in sudden death in children. J Forensic Sci 1977;22:188-96.
3. Frick M, Pachinger O, Polzl G. [Myocarditis and sudden cardiac death in athletes. Diagnosis, treatment, and prevention]. Herz 2009;34:299-304.
4. Mahrholdt H, Sechtem U. Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: are we there yet? JACC Cardiovascular Imaging 2009;2:139-42.
5. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006;48:2085-93.
6. Bami K, Haddad T, Dick A, Dennie C, Dwivedi G. Noninvasive imaging in acute myocarditis. Curr Opin Cardiol 2016;31:217-23.
7. Bengel FM. Imaging of post-infarct inflammation: moving forward toward clinical application. Circ Cardiovasc Imaging 2016;9:e004713.
8. Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL, Troester MA et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 2014;289:7884-96.
9. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M et al. Imaging ath-erosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 2010;55:2527-35.
10. Garber JC, Barbee RW, Bielitzki JT, Clayton LA, Donovan JC, Kohn DF et al. Guide for the Care and Use of Laboratory Animals, 8th ed. Washington, DC: National Academies Press (US); 2011.
11. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990;57:250-62.
12. Schmerler P, Jeuthe S, Oh-Ici D, Wassilew K, Lauer D, Kaschina E et al. Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats. Acta Physiol 2014;210:889-98.
13. 11C-me-thionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis. J Nucl Med 2016;57:1985-90.
14. Disselhorst JA, Brom M, Laverman P, Slump CH, Boerman OC, Oyen WJ et al. Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. J Nucl Med 2010;51:610-7.
15. Lapa C, Arias-Loza P, Hayakawa N, Wakabayashi H, Werner RA, Chen X et al. Whitening and impaired glucose utilization of brown adipose tissue in a rat model of type 2 diabetes mellitus. Sci Rep 2017;7:16795.
16. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003;2:131-7.
17. Higuchi T, Fukushima K, Rischpler C, Isoda T, Javadi MS, Ravert H et al. Stable delineation of the ischemic area by the PET perfusion tracer 18F-fluorobenzyl tri-phenyl phosphonium after transient coronary occlusion. J Nucl Med 2011;52:965-9.
18. Higuchi T, Nekolla SG, Jankaukas A, Weber AW, Huisman MC, Reder S et al. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med 2007;48:288-94.
19. Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 2011;15:981-95.
20. Klein D, Hohn HP, Kleff V, Tilki D, Ergun S. Vascular wall-resident stem cells. Histol Histopathol 2010;25:681-9.
21. Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X, Chatila K et al. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol 2008;180:2625-33.
22. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007;50:1914-31.
23. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34: 2636-48, 2648a-2648d.
24. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
25. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7:213-21.
26. Yoshida T, Hanawa H, Toba K, Watanabe H, Watanabe R, Yoshida K et al. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res 2005;68: 278-88.
27. Mackie AR, Losordo DW. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J 2011;38:474-85.
28. Brunner S, Theiss HD, Leiss M, Grabmaier U, Grabmeier J, Huber B et al. Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Basic Res Cardiol 2013; 108:388.
29. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-5.
30. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem 1997; 272:8013-8.
31. Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Günthert U et al. The osteopontin-CD44 pathway is superfluous for the development of autoimmune myocarditis. Eur J Immunol 2006;36:494-9.
32. Parish NM, Brennan F, Cooke A. Anti-CD44 treatment does not prevent the extravasation of autopathogenic T cells to the thyroid in experimental autoimmune thyroiditis. Immunology 1999;97:533-9.
33. Bennett MK, Gilotra NA, Harrington C, Rao S, Dunn JM, Freitag TB et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. Circ Heart Fail 2013;6:676-84.
34. Ozawa K, Funabashi N, Daimon M, Takaoka H, Takano H, Uehara M et al. Determination of optimum periods between onset of suspected acute myocarditis and (1)(8)F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. Int J Cardiol 2013;169: 196-200.
35. Korkusuz H, Esters P, Naguib N, Nour Eldin NE, Lindemayr S, Huebner F et al. Acute myocarditis in a rat model: late gadolinium enhancement with histopatho-logical correlation. Eur Radiol 2009;19:2672-8.
36. 18F-FDG PET/MRI in the evaluation of cardiac sar-coidosis and myocarditis. Clin Nucl Med 2017;42:e328-34.
37. Camargo PR, Mazzieri R, Snitcowsky R, Higuchi ML, Meneghetti JC, Soares JJ et al. Correlation between gallium-67 imaging and endomyocardial biopsy in children with severe dilated cardiomyopathy. Int J Cardiol 1990;28:293-7.
38. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001;7:1347-52.
39. Lee SP, Im HJ, Kang S, Chung SJ, Cho YS, Kang H et al. Noninvasive imaging of myocardial inflammation in myocarditis using 68Ga-tagged mannosylated human serum albumin positron emission tomography. Theranostics 2017;7:413-24.
40. Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T. New horizons in cardiac innervation imaging: introduction of novel (18)F-labeled PET tracers. Eur J Nucl Med Mol Imaging 2017;44:2302-9.
41. 123I-MIBG. J Nucl Med 2015;56: 1429-33.
42. Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET/MRI. J Nucl Cardiol 2018;25:785-94.
43. Thackeray JT, Bankstahl JP, Wang Y, Wollert KC, Bengel FM. Clinically relevant strategies for lowering cardiomyocyte glucose uptake for (18)F-FDG imaging of myocardial inflammation in mice. Eur J Nucl Med Mol Imaging 2015;42:771-80.
44. 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005;46:917-22.